George D. Yancopoulos - 29 Apr 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Bd. Co-Chair, President & CSO, Director
Signature
/s/**George D. Yancopoulos
Issuer symbol
REGN
Transactions as of
29 Apr 2024
Net transactions value
$0
Form type
4
Filing time
01 May 2024, 16:03:45 UTC
Previous filing
20 Feb 2024
Next filing
17 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -36,296 -100% $0.000000* 0 29 Apr 2024 by 2022 GRAT I
transaction REGN Common Stock Gift $0 +18,148 $0.000000 18,148 29 Apr 2024 by Children
holding REGN Common Stock 886,383 29 Apr 2024 Direct
holding REGN Common Stock 5,903 29 Apr 2024 By 401(k) Plan
holding REGN Common Stock 180,000 29 Apr 2024 By Trust for Chldn. F1
holding REGN Common Stock 158,410 29 Apr 2024 by 2022 GRAT II
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As investment trustee of trusts for the benefit of the reporting person's children.